| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.24 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.02 |